Brief: Zenas Biopharma Inc Files For Mixed Shelf- SEC Filing
08/10/2025 23:36
Oct 8 (Reuters) - Zenas Biopharma Inc ZBIO.O: ZENAS BIOPHARMA INC FILES FOR MIXED SHELF- SEC FILING ZENAS BIOPHARMA: AT-THE-MARKET OFFERING PROSPECTUS COVERING OFFER OF UP TO $200 MILLION COMMON STOCK THAT MAY BE ISSUED UNDER SALES AGREEMENT Source text: [ID:n0001104659-25-097950] Further company coverage: ZBIO.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Zenas BioPharma
See all newsBrief: Zenas Biopharma Announces Upcoming Presentations Of Obexelimab Data In Igg4-Related Disease At The Igg4ward! 6Th International Symposium On Igg4-Related Disease And Acr Convergence 2026
Brief: Zenas BioPharma Files For Offering Of Up To 7.0 Million Shares Of Common Stock By The Selling Stockholder - SEC Filing
Zenas BioPharma, Inc. reports results for the quarter ended June 30 - Earnings Summary
Brief: Zenas Biopharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Brief: Zenas Biopharma Says Phase 3 Indigo Trial Of Obexelimab Meets Primary And All Key Secondary Endpoints